Exercise and Health Education for Musculoskeletal Health in Industrial Workers
Health Chair: Exercise and Health Education Intervention at Profand Zaragoza
2 other identifiers
interventional
33
1 country
1
Brief Summary
This prospective, non-randomised interventional study aims to assess changes in musculoskeletal health, pain and physical activity among industrial workers following a health education and exercise programme adapted to their baseline musculoskeletal profile. Workers from production lines 8 and 9 at Profand Zaragoza will be allocated to one of two groups according to their baseline musculoskeletal symptoms, assessed using the Nordic Musculoskeletal Questionnaire. The reference group will receive a health education session, while workers with a higher baseline musculoskeletal burden will receive the same health education session together with a specific exercise programme consisting of supervised face-to-face and asynchronous home-based sessions. The primary outcome is perceived pain intensity measured using the Numeric Rating Scale (NRS). Secondary outcomes include musculoskeletal symptoms and physical activity. In the specific intervention group, health-related quality of life and physical function will also be assessed. Outcomes will be evaluated at baseline, after the intervention and at three-month follow-up. Changes over time will be analysed separately within each group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 21, 2026
CompletedStudy Start
First participant enrolled
September 22, 2026
CompletedFirst Posted
Study publicly available on registry
September 28, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
October 2, 2026
September 1, 2026
5 months
September 21, 2026
September 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in pain intensity assessed with the Numeric Rating Scale (NRS)
Perceived general pain intensity will be assessed using an 11-point Numeric Rating Scale (NRS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst pain imaginable. Changes from baseline will be assessed after the intervention and at follow-up.
Baseline, immediately after completion of the intervention period, and 3 months after the post-intervention assessment
Secondary Outcomes (8)
Change in musculoskeletal symptoms assessed with the Nordic Musculoskeletal Questionnaire
Baseline, immediately after completion of the intervention period, and 3 months after the post-intervention assessment
Change in physical activity assessed with the International Physical Activity Questionnaire-Short Form (IPAQ-SF)
Baseline, immediately after completion of the intervention period, and 3 months after the post-intervention assessment
Change in health-related quality of life assessed with the EuroQol 5-Dimension 5-Level (EQ-5D-5L)
Baseline (T0), at the end of the 8-week intervention period (T1), and 3 months after T1 (T2).
Change in handgrip strength measured with a hand dynamometer
Baseline (T0), at the end of the 8-week intervention period (T1), and 3 months after T1 (T2).
30-Second Sit-to-Stand Test
Baseline (T0), at the end of the 8-week intervention period (T1), and 3 months after T1 (T2).
- +3 more secondary outcomes
Study Arms (2)
Reference Group
EXPERIMENTALParticipants without a higher baseline musculoskeletal burden according to the Nordic Musculoskeletal Questionnaire will receive one face-to-face health education session.
Specific Intervention Group
EXPERIMENTALParticipants with a higher baseline musculoskeletal burden according to the Nordic Musculoskeletal Questionnaire will receive the same face-to-face health education session as the reference group, together with a tailored exercise programme consisting of 8 face-to-face and 8 asynchronous home-based exercise sessions.
Interventions
One face-to-face health education session covering pain and coping/self-efficacy strategies, strength exercise, aerobic exercise, mobility, active breaks, sleep hygiene and healthy habits, stress management and emotional well-being, adherence and motivation, and a final discussion and review.
Participants will receive the same face-to-face health education session as the reference group, covering pain and coping/self-efficacy strategies, strength and aerobic exercise, mobility, active breaks, sleep hygiene and healthy habits, stress management and emotional well-being, adherence and motivation. In addition, participants will complete a tailored exercise programme consisting of 8 supervised face-to-face exercise sessions and 8 asynchronous home-based exercise session, corresponding to one face-to-face and one home-based session per week. Exercises will focus on general mobility and stability of the neck, wrist/hand, shoulder and thoracolumbar spine, as well as strengthening of the upper and lower limbs. Exercise difficulty and repetitions may be individually adapted according to each participant's response, perceived difficulty and tolerance. The home-based session will be delivered asynchronously through the RehBody digital platform.
Eligibility Criteria
You may qualify if:
- Current employment contract with Profand Zaragoza covering the full duration of study participation, including the follow-up period.
- Age between 18 and 65 years, inclusive.
- Availability to participate in the scheduled study sessions.
- Written informed consent provided before enrolment.
You may not qualify if:
- Uncontrolled musculoskeletal, neurological, cardiovascular, respiratory, or systemic disease that contraindicates physical exercise.
- Acute musculoskeletal injury, recent surgery, or traumatic condition that substantially limits participation in the physical assessments or exercise programme.
- Current pregnancy.
- Temporary work incapacity due to illness during the intervention period.
- Cognitive or communication impairment preventing the participant from understanding the study information, providing valid informed consent, or adequately following the instructions for the assessments and exercises.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Profand Zaragoza. Bari, 3
Zaragoza, Zaragoza, 50197, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 21, 2026
First Posted
September 28, 2026
Study Start
September 22, 2026
Primary Completion (Estimated)
March 1, 2027
Study Completion (Estimated)
March 1, 2027
Last Updated
October 2, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared with other researchers. Only aggregated and anonymised study results will be reported, with no disclosure of individual-level data or participant codes, in order to protect participant confidentiality.